Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 21-22/2015

01.11.2015 | original article

Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome

verfasst von: MD Yusuf I. Alihanoglu, MD Bekir S. Yildiz, MD Emin E. Özcan, MD Dogu I. Kilic, MD Deniz S. Kuru, MD Ozgur Taskoylu, MD Halil Tanriverdi, MD Havane A. Kaftan, MD Harun Evrengul

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2015

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Metabolic syndrome (MS) refers to a group of cardiovascular risk factors associated with endothelial dysfunction and impaired coronary blood flow (CBF). Homocysteine (Hcy) is another risk factor for the development of insulin resistance and endothelial dysfunction. However, the relationship between Hcy levels and CBF in patients with MS has not been investigated specifically. In the present study, we aimed to evaluate the relationship between Hcy levels and CBF in MS patients with normal coronary arteries.

Methods

The study population included 36 patients with MS (20 males, 16 females; mean age = 55 ± 9 years) and 36 control subjects (20 males, 16 females; mean age = 51 ± 7 years). All subjects had angiographically proven normal coronary arteries. Plasma Hcy concentrations were evaluated after a fast of 12 h or longer. The CBF rates of all subjects were documented by the thrombolysis in myocardial infarction (TIMI) frame count method.

Results

The TIMI frame counts for each major epicardial coronary artery and mean TIMI frame count were found to be significantly higher in the MS group compared with the control group (left anterior descending coronary artery (LAD): 53 ± 26 vs. 39 ± 17; p = 0.01, left circumflex artery (LCx): 32 ± 12 vs. 26 ± 11; p = 0.01, right coronary artery (RCA): 33 ± 14 vs. 26 ± 12; p = 0.02, mean TIMI frame count: 39 ± 16 vs. 20 ± 12; p = 0.01). Plasma Hcy levels in patients with MS were significantly higher compared with controls (MS group = 11.6 ± 4 and control group = 9.6 ± 2.6; p = 0.01). Additionally, plasma Hcy levels were positively correlated with each calculated TIMI frame count value in the MS group (LAD, r: 0.28 and p = 0.006; LCx, r: 0.25 and p = 0.022; RCA, r: 0.26 and p = 0.042; mean TIMI frame count, r: 0.28 and p = 0.004).

Conclusion

Plasma Hcy levels and TIMI frame counts were significantly higher in patients with MS. Impaired CBF in MS may be related to elevated levels of Hcy, even if Hcy levels are normal.
Literatur
1.
Zurück zum Zitat Ninomiya JK, L’Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutritional examination survey. Circulation. 2004;109:42–6. CrossRefPubMed Ninomiya JK, L’Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutritional examination survey. Circulation. 2004;109:42–6. CrossRefPubMed
2.
Zurück zum Zitat Quiñones MJ, Hernandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenez X, Hernandez G, De La, Rosa R, Chon Y, Yang H, Nicholas SB, Modilevsky T, Yu K, Van Herle K, Castellani LW, Elashoff R, Hsueh WA. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med. 2004;140:700–8. CrossRefPubMed Quiñones MJ, Hernandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenez X, Hernandez G, De La, Rosa R, Chon Y, Yang H, Nicholas SB, Modilevsky T, Yu K, Van Herle K, Castellani LW, Elashoff R, Hsueh WA. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med. 2004;140:700–8. CrossRefPubMed
3.
Zurück zum Zitat Pırat B, Bozbaş H, Şimsek V, Yıldırır A, Sade LE, Gürsoy Y, Altın C, Atar I, Muderrisoglu H. Impaired coronary flow reserve in patients with metabolic syndrome. Atherosclerosis. 2008;201:112–6. CrossRefPubMed Pırat B, Bozbaş H, Şimsek V, Yıldırır A, Sade LE, Gürsoy Y, Altın C, Atar I, Muderrisoglu H. Impaired coronary flow reserve in patients with metabolic syndrome. Atherosclerosis. 2008;201:112–6. CrossRefPubMed
4.
Zurück zum Zitat Turhan H, Erbay AR, Yasar AS, Bicer A, Sasmaz H, Yetkin E. Impaired coronary blood flow in patients with metabolic syndrome: documented by Thrombolysis in Myocardial Infarction (TIMI) frame count method. Am Heart J. 2004;148:789–94. CrossRefPubMed Turhan H, Erbay AR, Yasar AS, Bicer A, Sasmaz H, Yetkin E. Impaired coronary blood flow in patients with metabolic syndrome: documented by Thrombolysis in Myocardial Infarction (TIMI) frame count method. Am Heart J. 2004;148:789–94. CrossRefPubMed
5.
Zurück zum Zitat Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879–88. CrossRefPubMed Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879–88. CrossRefPubMed
6.
Zurück zum Zitat Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D’Agostino RB Sr, Wilson PW. Framingham offspring study. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care. 2001;24:1403–10. CrossRefPubMed Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D’Agostino RB Sr, Wilson PW. Framingham offspring study. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care. 2001;24:1403–10. CrossRefPubMed
7.
Zurück zum Zitat Virtanen JK, Voutilainen S, Alfthan G, Korhonen MJ, Rissanen TH, Mursu J, Kaplan GA, Salonen JT. Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factors (KIHD) study. J Intl Med. 2005;257:255–62. CrossRef Virtanen JK, Voutilainen S, Alfthan G, Korhonen MJ, Rissanen TH, Mursu J, Kaplan GA, Salonen JT. Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factors (KIHD) study. J Intl Med. 2005;257:255–62. CrossRef
8.
Zurück zum Zitat Blom HJ. Consequences of homocysteine export and oxidation in the vascular system. Semin Thromb Hemost. 2000;26:227–32. CrossRefPubMed Blom HJ. Consequences of homocysteine export and oxidation in the vascular system. Semin Thromb Hemost. 2000;26:227–32. CrossRefPubMed
9.
Zurück zum Zitat He L, Zeng H, Li F, Feng J, Liu S, Liu J, Yu J, Mao J, Hong T, Chen AF, Wang X, Wang G. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. Am J Physiol Endocrinol Metab. 2010;299:1061–5. CrossRef He L, Zeng H, Li F, Feng J, Liu S, Liu J, Yu J, Mao J, Hong T, Chen AF, Wang X, Wang G. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. Am J Physiol Endocrinol Metab. 2010;299:1061–5. CrossRef
10.
Zurück zum Zitat Evrengul H, Tanriverdi H, Enli Y, Kuru O, Seleci D, Bastemir M, Kilic A, Kaftan A, Kilic M. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon. Cardiology. 2007;108(3):186–92. CrossRefPubMed Evrengul H, Tanriverdi H, Enli Y, Kuru O, Seleci D, Bastemir M, Kilic A, Kaftan A, Kilic M. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon. Cardiology. 2007;108(3):186–92. CrossRefPubMed
11.
Zurück zum Zitat Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A, Kaftan A, Kirac S, Kilic M. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter. 2007;12:298–305. CrossRefPubMed Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A, Kaftan A, Kirac S, Kilic M. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter. 2007;12:298–305. CrossRefPubMed
12.
Zurück zum Zitat Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41. CrossRefPubMed Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41. CrossRefPubMed
13.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. CrossRefPubMed
14.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–96. CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–96. CrossRef
15.
Zurück zum Zitat Cetin M, Zencir C, Tasolar H, Baysal E, Balli M, Akturk E. The association of serum albumin with coronary slow flow. Wien Klin Wochenschr. 2014;126:468–73. CrossRefPubMed Cetin M, Zencir C, Tasolar H, Baysal E, Balli M, Akturk E. The association of serum albumin with coronary slow flow. Wien Klin Wochenschr. 2014;126:468–73. CrossRefPubMed
16.
Zurück zum Zitat Epstein SE, Cannon O, Talbot TL. Hemodynamic principles in the control of coronary blood flow. Am J Cardiol. 1985;56:4–10. CrossRef Epstein SE, Cannon O, Talbot TL. Hemodynamic principles in the control of coronary blood flow. Am J Cardiol. 1985;56:4–10. CrossRef
17.
Zurück zum Zitat Fabian E, Kickinger A, Wagner KH, Elmadfa I. Homocysteine and asymmetric dimethylarginine in relation to B vitamins in elderly people. Wien Klin Wochenschr. 2011;123:496–501. CrossRefPubMed Fabian E, Kickinger A, Wagner KH, Elmadfa I. Homocysteine and asymmetric dimethylarginine in relation to B vitamins in elderly people. Wien Klin Wochenschr. 2011;123:496–501. CrossRefPubMed
18.
19.
Zurück zum Zitat Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost. 2005;3:1646–54. CrossRefPubMed Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost. 2005;3:1646–54. CrossRefPubMed
20.
Zurück zum Zitat Cattaneo M. Hyperhomocysteinemia and thrombosis. Lipids. 2001;36:13–26. CrossRef Cattaneo M. Hyperhomocysteinemia and thrombosis. Lipids. 2001;36:13–26. CrossRef
21.
Zurück zum Zitat Hajer GR, van der Graaf Y, Olijhoek JK, Verhaar MC, Visseren FL; SMART Study Group. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart. 2007;93:216–20. CrossRefPubMed Hajer GR, van der Graaf Y, Olijhoek JK, Verhaar MC, Visseren FL; SMART Study Group. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart. 2007;93:216–20. CrossRefPubMed
22.
Zurück zum Zitat Björck J, Hellgren M, Rastam L, Lindblad U. Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project. Metabolism. 2006;55:1007–13. CrossRefPubMed Björck J, Hellgren M, Rastam L, Lindblad U. Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project. Metabolism. 2006;55:1007–13. CrossRefPubMed
23.
Zurück zum Zitat Rosolova H, Simon J, Mayer O Jr, Racek J, Dierze T, Jacobsen DW. Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. Physiol Res. 2002;51:93–8. PubMed Rosolova H, Simon J, Mayer O Jr, Racek J, Dierze T, Jacobsen DW. Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. Physiol Res. 2002;51:93–8. PubMed
24.
Zurück zum Zitat Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab. 2001;86:719–23. PubMed Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab. 2001;86:719–23. PubMed
25.
Zurück zum Zitat Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia. 1998;41:684–93. CrossRefPubMed Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia. 1998;41:684–93. CrossRefPubMed
26.
Zurück zum Zitat Audelin MC, Genest J Jr. Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis. 2001;159:497–511. CrossRefPubMed Audelin MC, Genest J Jr. Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis. 2001;159:497–511. CrossRefPubMed
27.
Zurück zum Zitat Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47–53. CrossRefPubMed Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47–53. CrossRefPubMed
28.
Zurück zum Zitat Hayden MR, Tyagi SC. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J. 2004;3:1–23. CrossRef Hayden MR, Tyagi SC. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J. 2004;3:1–23. CrossRef
29.
Zurück zum Zitat Sezgin N, Barutcu I, Sezgin AT, Gullu H, Turkmen M, Esen AM, Karakaya O. Plasma nitric oxide level and its role in slow coronary flow phenomenon. Int Heart J. 2005;46:373–82. CrossRefPubMed Sezgin N, Barutcu I, Sezgin AT, Gullu H, Turkmen M, Esen AM, Karakaya O. Plasma nitric oxide level and its role in slow coronary flow phenomenon. Int Heart J. 2005;46:373–82. CrossRefPubMed
30.
Zurück zum Zitat Tanriverdi H, Evrengul H, Enli Y, Kuru O, Seleci D, Tanriverdi S, Tuzun N, Kaftan HA, Karabulut N. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. Cardiology. 2007;107:313–20. CrossRefPubMed Tanriverdi H, Evrengul H, Enli Y, Kuru O, Seleci D, Tanriverdi S, Tuzun N, Kaftan HA, Karabulut N. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. Cardiology. 2007;107:313–20. CrossRefPubMed
31.
Zurück zum Zitat Arnett EN, Isner JM, Redwood DR, Kent KM, Baker WP, Ackerstein H, Roberts WC, et al. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med. 1979;91:350–6. CrossRefPubMed Arnett EN, Isner JM, Redwood DR, Kent KM, Baker WP, Ackerstein H, Roberts WC, et al. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med. 1979;91:350–6. CrossRefPubMed
Metadaten
Titel
Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome
verfasst von
MD Yusuf I. Alihanoglu
MD Bekir S. Yildiz
MD Emin E. Özcan
MD Dogu I. Kilic
MD Deniz S. Kuru
MD Ozgur Taskoylu
MD Halil Tanriverdi
MD Havane A. Kaftan
MD Harun Evrengul
Publikationsdatum
01.11.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 21-22/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0854-z